Blood collection
Blood collection is an intervention with 167 clinical trials. Currently 41 active trials ongoing. Historical success rate of 84.4%.
Success Metrics
Based on 76 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
2
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.8%
76 of 99 finished
23.2%
23 ended early
41
trials recruiting
167
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Defining the Severe Paediatric Asthma Endotype
The HIV, Adipose Tissue Immunology, and Metabolism Study
Cell-based Non-invasive Prenatal Test Workflow
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Clinical Trials (167)
Defining the Severe Paediatric Asthma Endotype
The HIV, Adipose Tissue Immunology, and Metabolism Study
Cell-based Non-invasive Prenatal Test Workflow
A Combined Biomarker Model for Risk Stratification of Indeterminate Pulmonary Nodules
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Determine Immunoglobulin G4 (IgG4) Standards for Cow's Milk and Egg in Different Populations of Allergic and Non-allergic Children
Study of the Immunological and Virological Response of Patients With COVID-19 and Presenting an Asymptomatic or Pauci-symptomatic Form (AMBUCOV)
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
Peripheral and Intrarenal B Cell Study in Antibody Mediated Transplant Rejection : Phenotypic and Transcriptional Study, Study of Reactivity
Weekly Paclitaxel and Cyclophosphamide in Metronomic Administration : Dose Escalation Study of Weekly Paclitaxel
Genetics Of Autoimmunity In Type I Diabetes
Hiatal Hernia and Pulmonary Involvement
Tryptophan as a Modulating Factor in the Antimigraine Efficacy of Triptans
Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy
Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Positron Emission Tomography (PET) Imaging of Thrombosis
The APS Phenotyping Study
Longitudinal Study of Intra-Uterine Growth Restriction
Cardiotoxicity of Cancer Therapy (CCT)
CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 167